Brief: Iveric Bio - On March 14, Co Entered Into Commercial Manufacturing And Supply Agreement With Agilent Technologies
March 20 (Reuters) - Agilent Technologies Inc A.N :
* IVERIC BIO - ON MARCH 14, CO ENTERED INTO COMMERCIAL
MANUFACTURING AND SUPPLY AGREEMENT WITH AGILENT TECHNOLOGIES
* IVERIC BIO - COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENT
IS
RELATING TO COMMERCIAL MANUFACTURING AND SUPPLY OF AVACINCAPTAD
PEGOL DRUG SUBSTANCE
Further company coverage: A.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini